A publication co-authored by Ludwig Kappos and collaborators has been recognized among the Top 10% most-viewed papers published in 2024 in Annals of Neurology, the official journal of the American Neurological Association.
The article, titled “Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis”, explores the role of blood-based biomarkers in reflecting distinct mechanisms of disease progression in Multiple Sclerosis under B-cell depleting therapies.
This recognition highlights the scientific impact and visibility of the work within the international neurology and Multiple Sclerosis research communities. Further, it emphasizes the importance of translational and biomarker-driven research in advancing precision medicine approaches for neuroinflammatory diseases.
We warmly congratulate all authors and collaborators involved in this achievement.
Don’t miss the original publication:
